Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 9/20 | 0.69 |
| ▸ | HSD17B2 | P37059 | 9/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.54 |
| ▸ | KDM1A | O60341 | 2/20 | 0.54 |
| ▸ | CCR1 | P32246 | 1/20 | 0.52 |
| ▸ | CCR5 | P51681 | 1/20 | 0.52 |
| ▸ | CCR8 | P51685 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | FYN | P06241 | 4/20 | 0.49 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30610289 | 1.00 | HSD17B1 (0.69) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL503090 | 0.87 | CYP3A4 (0.63) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL12797772 | 0.83 | CYP3A4 (0.59) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL6068227 | 0.83 | CCR1 (0.58) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL1181050 | 0.81 | HSD17B1 (1.00) | HSD17B1HSD17B2CYP3A4KDM1AFYN | |
| SCHEMBL1180306 | 0.81 | HSD17B1 (1.00) | HSD17B1HSD17B2CYP3A4KDM1AHDAC6 | |
| SCHEMBL2480995 | 0.80 | CYP3A4 (0.56) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL3878084 | 0.79 | HSD17B1 (0.54) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL17776911 | 0.79 | CYP3A4 (0.54) | HSD17B1HSD17B2CYP3A4CYP2A6KDM1A | |
| SCHEMBL10264655 | 0.79 | CYP3A4 (0.54) | CYP3A4CYP2A6KDM1ACCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-10-15 | — | — | US | disclosed |
| CN-117279468-A | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-12-22 | — | — | CN | disclosed |
| CN-111527615-B | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-10-17 | — | — | CN | disclosed |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-03 | — | — | US | disclosed |
| US-20210193936-A1 | PHOSPHORESCENT EXCIMERS WITH PREFERRED MOLECULAR ORIENTATION AS MONOCHROMATIC EMITTERS FOR DISPLAY AND LIGHTING APPLICATIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-06-24 | — | — | US | disclosed |
| CN-111527615-A | Phosphorescent excimer molecules with preferred molecular orientation as monochromatic emitters for display and lighting applications | 李健 | 2020-08-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210193936-A1 | PHOSPHORESCENT EXCIMERS WITH PREFERRED MOLECULAR ORIENTATION AS MONOCHROMATIC EMITTERS FOR DISPLAY AND LIGHTING APPLICATIONS | PDCD1LG2, DCX, EMC2 | HSD17B1 4482/4885HSD17B2 3833/4885CYP3A4 4281/4885 |
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | PDCD1LG2, EML4, EMC3 | HSD17B1 4231/4885HSD17B2 3519/4885CYP3A4 3674/4885 |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | PDCD1LG2, DCX, EMC2 | HSD17B1 4482/4885HSD17B2 3833/4885CYP3A4 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.